Winton Matthew

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Winton Matthew
CIK #0001971400
EDGAR Form CIK 2011 - 2026
3 [0001971400]
4 [0001971400]
Form 3/4/5 Subject 2011 - 2026
RestorGenex Corp
Winton Matthew
Inozyme Pharma Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
RestorGenex Corp CRVO
Stock Option (Right to Buy) · derivative
2026-02-11 Grant 30,000 $0.00
RestorGenex Corp CRVO
Common Stock
2025-11-18 Buy 1,500 $7.95 11,925
RestorGenex Corp CRVO
Common Stock
2025-11-17 Buy 3,500 $8.43 29,505
RestorGenex Corp CRVO
Common Stock
2025-11-14 Buy 10,000 $7.57 75,700
RestorGenex Corp CRVO
Stock Option (Right to Buy) · derivative
2025-10-06 Grant 75,000 $0.00
Inozyme Pharma Inc INZY
Restricted Stock Units · derivative
2025-07-01 Disposed to issuer 41,500
Inozyme Pharma Inc INZY
Common Stock
2025-07-01 Tender 21,743 $4.00 86,972
Inozyme Pharma Inc INZY
Stock Option (Right to Buy) · derivative
2025-07-01 Disposed to issuer 145,000
Inozyme Pharma Inc INZY
Common Stock
2025-06-25 Grant 14,355 $0.74 10,623
Inozyme Pharma Inc INZY
Common Stock
2025-03-31 Grant 2,490 $0.77 1,917
Inozyme Pharma Inc INZY
Stock Option (right to buy) · derivative
2025-03-11 Grant 145,000 $0.00
Inozyme Pharma Inc INZY
Restricted Stock Units · derivative
2025-03-11 Grant 41,500 $0.00
Inozyme Pharma Inc INZY
Common Stock
2024-09-30 Grant 1,710 $4.45 7,610
Inozyme Pharma Inc INZY
Common Stock
2024-03-28 Grant 3,188 $3.33 10,616
Inozyme Pharma Inc INZY
Stock Option (right to buy) · derivative
2024-03-13 Grant 175,000 $0.00
Inozyme Pharma Inc INZY
Stock option (right to buy) · derivative
2023-04-03 Grant 250,000 $0.00
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com